Early and Effective Nutritional Therapy in GI Cancer Patients: An Opportunity to Improve Patient Outcomes & Quality of Life
Retrieved on:
Thursday, September 26, 2019
Baxter International Inc. (NYSE: BAX), a global leader in clinical nutrition, is also present at the ESMO congress to be held in Barcelona from 27 September to 1 October, organizing the symposium Early and effective nutritional therapy in GI cancer patients: an opportunity to improve outcome.
Key Points:
- Baxter International Inc. (NYSE: BAX), a global leader in clinical nutrition, is also present at the ESMO congress to be held in Barcelona from 27 September to 1 October, organizing the symposium Early and effective nutritional therapy in GI cancer patients: an opportunity to improve outcome.
- Approximately 50% of oncology patients in Europe are affected by malnutrition.
- 2 Hu W-H et al.
- Lee H et al.